Old drugs plus SARS equals new INDs and M&A pressure wave

Old drugs plus SARS equals new INDs and M&A pressure wave

There is pressure for M&A and raised valuation multiples in the kinase inhibitor market. The University of California San Francisco (UCSF) conducted a research study in April 2020 that took existing and approved drugs and investigated their ability to stop...

Continue reading →

Saving the Care Home healthcare segment – Technology, M&A and the State

Saving the Care Home healthcare segment – Technology, M&A and the State

David Grabowski, a Harvard Medical School professor who specialises in healthcare policy, in an interview with Yahoo Finance in July 2020 spoke to the crisis of the US care home industry pre-Covid. Prior to the pandemic care home facilities...

Continue reading →

Is the cost of monitoring employees at home worth the erosion of trust?

Is the cost of monitoring employees at home worth the erosion of trust?

Continue reading →